Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Can olanzapine be implicated in causing serotonin syndrome?

Christopher David Haslett1, Shailesh Kumar

  • 1Department of Psychiatry, Rotorua Hospital, Rotorua, New Zealand. cdhaslett@paradise.net.nz

Psychiatry and Clinical Neurosciences
|August 24, 2002
PubMed
Summary

A patient with bipolar disorder developed serotonin syndrome (SS) after adding olanzapine to lithium and citalopram. This case highlights the risk of SS when combining atypical antipsychotics with serotonergic drugs.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Chip-integrated metasurface-enabled single-photon skyrmion sources.

Nature communications·2026
Same author

When the Nerve Lies Between the Fragments: A Mid-Shaft Humeral Fracture Mimicking a Holstein-Lewis Injury.

Journal of orthopaedic case reports·2026
Same author

Prosthetic rehabilitation with dental implants after conservative management of odontogenic keratocyst of posterior mandible: A retrospective observational study.

National journal of maxillofacial surgery·2026
Same author

AtFusionDB: A Comprehensive Database of Fusion Transcripts in Model Plant Arabidopsis thaliana.

Methods in molecular biology (Clifton, N.J.)·2026
Same author

Validation of Plant Fusion Peptides Using Proteomics Data.

Methods in molecular biology (Clifton, N.J.)·2026
Same author

Comparative evaluation of antimicrobial efficacy for different root canal irrigants against <i>Enterococcus faecalis</i> - An <i>in vitro</i> study.

Bioinformation·2026

Area of Science:

  • Neuroscience
  • Psychiatry
  • Clinical Pharmacology

Background:

  • Serotonin syndrome (SS) is a potentially life-threatening condition caused by excessive serotonergic agonism.
  • Bipolar affective disorder is a mood disorder requiring complex pharmacotherapy.
  • Managing mood disorders often involves multiple psychotropic medications, increasing the risk of drug interactions.

Observation:

  • A patient diagnosed with bipolar affective disorder was treated with lithium and citalopram.
  • Olanzapine, an atypical antipsychotic, was added to the patient's medication regimen.
  • The patient subsequently developed symptoms consistent with serotonin syndrome.

Findings:

  • This case presents the first reported instance implicating olanzapine in the development of serotonin syndrome.

Related Experiment Videos

  • The combination of lithium, citalopram (a serotonergic agent), and olanzapine (an atypical antipsychotic) appears to have precipitated SS.
  • The patient's clinical presentation resolved upon discontinuation of the offending agents.

    • Implications:

    • Clinicians must exercise caution when prescribing atypical antipsychotics, such as olanzapine, concurrently with serotonergic medications.
    • Awareness of this potential drug interaction is crucial for preventing SS in patients with psychiatric disorders.
    • Further research may be warranted to elucidate the specific mechanisms underlying olanzapine-induced SS.